Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Nasdaq Real Time Price USD

Nautilus Biotechnology, Inc. (NAUT)

Compare
0.7580
+0.0347
+(4.80%)
At close: April 17 at 4:00:00 PM EDT
0.7875
+0.03
+(3.89%)
After hours: April 17 at 6:57:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
81,476
81,476
76,152
63,618
50,498
Operating Income
-81,476
-81,476
-76,152
-63,618
-50,498
Net Non Operating Interest Income Expense
10,780
10,780
12,550
5,816
329
Other Income Expense
-84
-84
-73
-122
-146
Pretax Income
-70,780
-70,780
-63,675
-57,924
-50,315
Net Income Common Stockholders
-70,780
-70,780
-63,675
-57,924
-50,315
Diluted NI Available to Com Stockholders
-70,780
-70,780
-63,675
-57,924
-50,315
Basic EPS
-0.56
--
-0.51
-0.46
-0.60
Diluted EPS
-0.56
--
-0.51
-0.46
-0.60
Basic Average Shares
125,426.5090
--
124,919.1440
124,589.5550
84,464.0810
Diluted Average Shares
125,426.5090
--
124,919.1440
124,589.5550
84,464.0810
Total Expenses
81,476
81,476
76,152
63,618
50,498
Net Income from Continuing & Discontinued Operation
-70,780
-70,780
-63,675
-57,924
-50,315
Normalized Income
-70,780
-70,780
-63,675
-57,924
-50,315
Interest Income
10,780
10,780
12,550
5,816
329
Net Interest Income
10,780
10,780
12,550
5,816
329
EBIT
-81,476
-81,476
-76,152
-63,618
-50,498
EBITDA
-75,123
-75,123
-70,447
-60,202
-47,656
Reconciled Depreciation
6,353
6,353
5,705
3,416
2,842
Net Income from Continuing Operation Net Minority Interest
-70,780
-70,780
-63,675
-57,924
-50,315
Normalized EBITDA
-75,123
-75,123
-70,447
-60,202
-47,656
12/31/2021 - 8/7/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

50BA.MU Bicycle Therapeutics PLC
6.80
+3.82%
 
B9A.MU BioArctic AB
15.18
-16.41%
 
CSJ.MU CSL Ltd
134.56
-0.83%
 
CSJ.BE CSL Ltd
134.60
-1.25%
 
301080.SZ Acrobiosystems Co.,Ltd.
43.16
+0.14%
 
ZH6.BE Biohaven Ltd. R
17.90
+10.49%
 
SEER Seer, Inc.
1.9700
-0.51%
 
REGN.VI Regeneron Pharmaceuticals, Inc.
490.00
-0.18%
 
6996.HK Antengene Corporation Limited
2.670
+2.69%
 
NRIX Nurix Therapeutics, Inc.
10.24
+4.49%